Eficacia clínica del calzado terapéutico con suela rígida en forma de balancín para la prevención de la reulceración en pacientes con diabetes mellitus y polineuropatía diabéticaensayo clínico aleatorizado

Laburpena

Diabetic foot ulcer (DFU) is one of the most common complications of diabetes mellitus. The lifetime incidence of DFU in patients with diabetes is approximately 19% to 34%. Moreover, approximately 20% of DFU with moderate or severe infection lead different levels of amputation.Patients with a history of DFU have a 2.5 times higher risk of death than those without history of DFU. The mortality rate increases to 70% at 5 years after undergoing an amputation. The costs of the treatment for diabetic foot complication are more expensive than those for more common cancer complications, amounting to76 billion annually in the United States.DFUs are caused by repetitive stress in patients with peripheral neuropathy, foot deformities, and peripheral arterial disease. The DFU recurrence rate is estimated at 40% after the first year of ulcer healing and 60% within 3 years, and it increases to 65% after 5 years...